AUM$14.9M
Expense Ratio0.50%
NAV$5.84
Holdings49
InceptionNov 2, 2021
Price Chart
Key Statistics
Previous Close
—Day Range
N/A52-Week Range
N/AAvg Volume
—Dividend Yield
—Expense Ratio
0.50%AUM
$14.9MShares Outstanding
—Sector Breakdown
| Sector | Weight % |
|---|---|
| Healthcare | 99.72% |
| Technology | 0.28% |
Country Allocation
| Country | Weight % |
|---|---|
| United States | 82.79% |
| Netherlands | 4.30% |
| Germany | 3.85% |
| Switzerland | 3.66% |
| United Kingdom | 2.27% |
| Singapore | 1.54% |
| China | 1.53% |
| Other | 0.06% |
Fund Information
- Issuer
- Global X
- Category
- Healthcare
- Inception Date
- Nov 2, 2021
- Description
- The Global X Genomics & Biotechnology UCITS ETF (GNOM LN) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive Genomics v2 Index.
Similar ETFs
The Global X - Genomics & Biotechnology UCITS ETF (GNOG.L) is an exchange-traded fund issued by Global X that launched on Nov 2, 2021. It currently manages $14.9M in assets under management. The fund charges an expense ratio of 0.50%. The fund holds 49 securities in its portfolio. It falls under the Healthcare category.
Top 10 holdings represent 51.3% of the fund
| Rank | Symbol | Name | Weight % | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | MRNA | MODERNA INC | 8.93% | 33,222 | $1.3M |
| 2 | PRAX | PRAXIS PRECISION MEDICINES I | 6.40% | 4,193 | $963K |
| 3 | ARWR | ARROWHEAD PHARMACEUTICALS IN | 5.64% | 20,366 | $849K |
| 4 | ILMN | ILLUMINA INC | 5.02% | 8,634 | $756K |
| 5 | GH | GUARDANT HEALTH INC | 4.80% | 11,356 | $723K |
| 6 | VRTX | VERTEX PHARMACEUTICALS INC | 4.73% | 1,966 | $712K |
| 7 | BMRN | BIOMARIN PHARMACEUTICAL INC | 4.71% | 15,823 | $708K |
| 8 | NTRA | NATERA INC | 4.08% | 4,255 | $613K |
| 9 | BNTX | BIONTECH SE-ADR | 3.60% | 7,940 | $542K |
| 10 | TECH | BIO-TECHNE CORP | 3.43% | 13,230 | $516K |
| 11 | QGEN | QIAGEN N.V. | 3.42% | 16,519 | $514K |
| 12 | CRSP | CRISPR THERAPEUTICS AG | 3.23% | 13,118 | $486K |
| 13 | BMY | BRISTOL-MYERS SQUIBB CO | 2.86% | 9,630 | $430K |
| 14 | ALNY | ALNYLAM PHARMACEUTICALS INC | 2.72% | 1,703 | $409K |
| 15 | GILD | GILEAD SCIENCES INC | 2.52% | 3,461 | $379K |
Detailed Returns
| Period | Return | ETF | Cat. Avg | vs Avg |
|---|---|---|---|---|
| 1D | — | — |
Moving Averages
20-Day MA
—
50-Day MA
—
200-Day MA
—
Price with Moving Averages
Support & Resistance
52-Week High
—
Current Price
—
52-Week Low
—
Current Yield
—
Annual Dividend
—
Frequency
—
Last Ex-Date
—
Dividends
No dividend data available for this ETF.
Category Comparison
| Metric | GNOG.L | Healthcare(223 ETFs) |
|---|---|---|
| Fund Info | ||
| Expense Ratio | 0.50% | 0.60% |
| AUM | $14.9M | $1.24B |
| Dividend Yield | — | 2.75% |
| Avg Volume | — | 800.9K |
| Holdings | 49 | 171 |
| Performance | ||
| 1-Month Return | — | -4.57% |
| 6-Month Return | — | +4.90% |
| YTD Return | — | -1.70% |
| 1-Year Return | — | +15.18% |
Compare with Another ETF
Search for an ETF to compare with GNOG.L: